ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,552Medicare Part D Prescriptions Filled, Including Refills

Rank: 162 out of 1844

$709K Total Retail Price of All Prescriptions

Rank: 144 out of 1844

509 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 509 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,750 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 417 357 1 1
OMEPRAZOLE 334 305 2 5
LISINOPRIL 326 289 3 4
AMLODIPINE BESYLATE 292 253 4 6
WARFARIN SODIUM 272 257 5 13
SIMVASTATIN 269 245 6 3
DONEPEZIL HCL 262 252 7 26
FUROSEMIDE 230 221 8 7
GABAPENTIN 209 168 9 15
POTASSIUM CHLORIDE 198 185 10 16
HYDROCODONE-ACETAMINOPHEN 193 135 S3 11 2
CARVEDILOL 178 144 12 22
CYMBALTA 173 160 13 36
TRAMADOL HCL 166 144 14 18
NAMENDA 165 165 15 33
PANTOPRAZOLE SODIUM 162 113 16 32
ESCITALOPRAM OXALATE 151 141 17 52
PRAVASTATIN SODIUM 150 133 18 10
METFORMIN HCL 130 89 19 8
LANTUS 127 98 20 42
CITALOPRAM HBR 125 100 21 19
CARBIDOPA-LEVODOPA 116 116 22 86
FAMOTIDINE 115 107 23 63
HYDROCHLOROTHIAZIDE 112 103 24 9
METOPROLOL TARTRATE 112 108 24 11
MIRTAZAPINE 111 107 26 49
METOPROLOL SUCCINATE 105 97 27 14
DIVALPROEX SODIUM 103 97 28 74
ATORVASTATIN CALCIUM 102 85 29 12
SPIRIVA 99 62 30 57
SERTRALINE HCL 90 72 31 21
JANUVIA 80 68 32 77
OXYBUTYNIN CHLORIDE 79 69 33 103
NOVOLOG 78 56 34 84
POLYETHYLENE GLYCOL 3350 77 68 35 39
ADVAIR DISKUS 76 31 36 51
DILTIAZEM 24HR ER 73 73 37 146
LEXAPRO 73 71 37 179
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 31 39 20
QUETIAPINE FUMARATE 72 67 39 82
SPIRONOLACTONE 71 61 41 60
LOSARTAN POTASSIUM 70 69 42 24
CLOPIDOGREL 69 64 43 34
CYCLOBENZAPRINE HCL 69 62 R 43 53
LEVOFLOXACIN 68 63 45 78
TAMSULOSIN HCL 67 60 46 27
ZOLPIDEM TARTRATE 67 56 46 23
CEPHALEXIN 61 48 48 56
OXYBUTYNIN CHLORIDE ER 58 49 49 126
BACLOFEN 58 42 49 119
DILTIAZEM 24HR CD 57 48 51 132
PREDNISONE 57 39 51 40
FENOFIBRATE 56 41 53 71
AZITHROMYCIN 54 40 54 37
RANITIDINE HCL 54 45 54 38
BUMETANIDE 53 33 56 121
KLOR-CON M20 52 33 57 54
RISPERIDONE 52 30 57 65
DOXYCYCLINE HYCLATE 52 49 57 90
LIDOCAINE 51 50 60 314
ATENOLOL 50 48 61 17
PROAIR HFA 50 30 61 45
DIOVAN 50 47 61 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.